36th ECNP Congress, Barcelona, Spain, 7 - 10 October 2023, vol.2, no.2023103863, pp.177-178
Schizophrenia (SCZ) is among the leading causes of disability
worldwide, affecting around 1% of the world population (1). Nevertheless,
biological mechanisms are still inadequately understood; growing evidence has
demonstrated that defects in immune-related genes present SCZ susceptibility (2,
3). IL-2 is a growth factor for T-cells, NK, and B cells (4). Association studies
examining polymorphisms of IL-2 (rs2069762) and IL-2RA (rs2104286) genes in
SCZ are limited; therefore, this study aims to evaluate the genetic polymorphisms
in IL-2 and IL-2RA genes in SCZ patients by comparing them with healthy
controls.